Cargando…

Triple A syndrome-related achalasia treated by per-oral endoscopic myotomy: Three case reports

BACKGROUND: Triple A syndrome is a rare autosomal recessive disease characterized by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima and achalasia. In the last 5 years, per-oral endoscopic myotomy (POEM) has proved highly successful in treating primary achalasia over the long t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feng-Chen, Feng, Yun-Lu, Yang, Ai-Ming, Guo, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294871/
https://www.ncbi.nlm.nih.gov/pubmed/35979302
http://dx.doi.org/10.12998/wjcc.v10.i19.6529
Descripción
Sumario:BACKGROUND: Triple A syndrome is a rare autosomal recessive disease characterized by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima and achalasia. In the last 5 years, per-oral endoscopic myotomy (POEM) has proved highly successful in treating primary achalasia over the long term, but its long-term performance has not been certified by achalasia related to Triple A syndrome. CASE SUMMARY: Triple A syndrome is a rare autosomal recessive disease characterized by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima and achalasia. In the past 5 years, POEM has proved highly successful in treating primary achalasia over the long term, but its long-term performance has not been certified by achalasia related to Triple A syndrome. Eckardt scores and esophageal manometry improved significantly during the 2 years following POEM; however, grade-A reflux esophagitis recurred in 66.7% of patients in 12 mo post-procedure. CONCLUSION: Based on these case studies, POEM is efficacious and safe for a treatment of achalasia associated with Triple A syndrome.